New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
10:00 EDTAGN, VOLVY, WOOF, VAL, UCTT, TREX, SANM, RLGY, INWK, HBAN, HAS, EGAS, FIVE, DLR, FANG, CYS, BMRC, AXL, ZIONOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Buy from Neutral at UBS... American Axle (AXL) upgraded to Neutral from Underweight at JPMorgan... Bank of Marin (BMRC) upgraded to Buy from Hold at Sandler O'Neill... CYS Investments (CYS) upgraded to Buy from Hold at Wunderlich... Diamondback Energy (FANG) upgraded to Buy from Neutral at Roth Capital... Digital Realty (DLR) upgraded to Buy from Hold at Deutsche Bank... Five Below (FIVE) upgraded to Outperform from Market Perform at Wells Fargo... Gas Natural (EGAS) upgraded to Buy from Hold at Wunderlich... Hasbro (HAS) upgraded to Overweight from Equal Weight at Barclays... Huntington Bancshares (HBAN) upgraded to Outperform at Keefe Bruyette... InnerWorkings (INWK) upgraded to Buy from Hold at Feltl... Realogy (RLGY) upgraded to Buy from Neutral at Citigroup... Sanmina (SANM) upgraded to Hold from Sell at Deutsche Bank... Trex Company (TREX) upgraded at Stifel... Ultra Clean (UCTT) upgraded to Buy from Neutral at Roth Capital... VCA Inc. (WOOF) upgraded at Stifel... Valspar (VAL) upgraded to Conviction Buy from Neutral at Goldman... Volvo (VOLVY) upgraded to Neutral from Sell at Goldman... Zions Bancorp (ZION) upgraded to Buy from Neutral at Compass Point.
News For AGN;AXL;BMRC;CYS;FANG;DLR;FIVE;EGAS;HAS;HBAN;INWK;RLGY;SANM;TREX;UCTT;VAL;WOOF;VOLVY;ZION From The Last 14 Days
Check below for free stories on AGN;AXL;BMRC;CYS;FANG;DLR;FIVE;EGAS;HAS;HBAN;INWK;RLGY;SANM;TREX;UCTT;VAL;WOOF;VOLVY;ZION the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 9, 2014
16:04 EDTAGNPershing Square reports 9.7% stake in Allergan, sends letter to board
Pershing Square Capital Management sent a letter to the board of Allergan that highlights several reasons why Allergan is extremely shareholder unfriendly and why now is the time for Allergan's management team to wake up. In the letter, Pershing Square said: "Since the bid was announced in April, 75% of Allergan’s shareholders have sold all or a portion of their investment including the company’s largest shareholder, which has sold its entire position. These shareholders are sending the board a message. They would not have sold if they believed that Allergan stock was worth more than current values... We note CFO Jeff Edwards recent decision to retire from the company at age 53 for family reasons, and his replacement by an investor relations executive rather than an experienced public company CFO. The notion that Allergan should execute the largest acquisition in its history led by an investor relations executive is a frightening proposition. While we respect an executive’s need to retire from a company for family reasons, Edwards exit also calls into question the company’s forward earnings guidance which shareholders expected him to execute on when the Company presented these projections on July 21st. I had expected that at some point one or more directors would have woken up and smelled the coffee. There is still time for a subset of directors to rescue their reputations by taking over leadership of this process from David Pyott and his handpicked advisors and doing what you are paid $400,000 per year to do on behalf of the company’s owners."
07:15 EDTWOOFCL King to hold a conference
Subscribe for More Information
06:42 EDTAGNLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
September 8, 2014
17:12 EDTSANMSanmina announces new $100M share repurchase plan
Subscribe for More Information
07:21 EDTAGNJazz looks more attractive for Allergan than Salix, says Wells Fargo
Subscribe for More Information
September 5, 2014
10:28 EDTSANMHigh option volume stocks
Subscribe for More Information
10:05 EDTAGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Actavis (ACT) initiated with a Buy at ISI Group... Akamai (AKAM) initiated with a Buy at UBS... Alexion (ALXN) initiated with a Buy at SunTrust... Allegion (ALLE) initiated with a Buy at Buckingham... Allergan (AGN) initiated with a Buy at ISI Group... Aviat Networks (AVNW) initiated with a Neutral at H.C. Wainwright... Celgene (CELG) initiated with a Buy at SunTrust... EZCORP (EZPW) initiated with a Hold at Jefferies... Eaton (ETN) initiated with a Neutral at Buckingham... Emerson (EMR) initiated with a Neutral at Buckingham... HMS Holdings (HMSY) initiated with an Overweight at Stephens... Incyte (INCY) initiated with a Buy at SunTrust... Ingersoll-Rand (IR) initiated with a Neutral at Buckingham... Insmed (INSM) initiated with an Outperform at Cowen... Intercept (ICPT) initiated with an Outperform at Cowen... Johnson & Johnson (JNJ) initiated with an Outperform at BMO Capital... Lennox (LII) initiated with a Neutral at Buckingham... Mylan (MYL) initiated with a Hold at ISI Group... Orion Engineered Carbons (OEC) initiated with a Buy at Goldman... Parker-Hannifin (PH) initiated with a Buy at Buckingham... Pentair (PNR) initiated with a Neutral at Buckingham... Pharmacyclics (PCYC) initiated with a Neutral at SunTrust... Rockwell Automation (ROK) initiated with a Neutral at Buckingham... Sabre (SABR) initiated with an Outperform at Oppenheimer... Santander Consumer (SC) initiated with a Buy at Jefferies... Springleaf (LEAF) initiated with a Buy at Jefferies... Susser Petroleum (SUSP) initiated with a Neutral at Credit Suisse... Teva (TEVA) initiated with a Buy at ISI Group... Valeant (VRX) initiated with a Buy at ISI Group... WESCO (WCC) initiated with a Neutral at Buckingham... Watsco (WSO) initiated with a Neutral at Buckingham... Weyerhaeuser (WY) initiated with a Neutral at JPMorgan... World Acceptance (WRLD) initiated with a Hold at Jefferies.
07:47 EDTINWKInnerWorkings management to meet with Barrington
Subscribe for More Information
September 4, 2014
21:18 EDTVALValspar management to meet with JPMorgan
Subscribe for More Information
19:12 EDTAGNAllergan provides update on requests from Pershing regarding special meeting
Subscribe for More Information
17:17 EDTAGNAllergan initiated with a Buy at ISI Group
Subscribe for More Information
11:06 EDTTREXTrex Company initiated with a Buy at Sidoti (pre-open)
Target $47.
09:44 EDTAGNValeant, Ackman deliver another 2.8% consent vote to Allergan, CNBC reports
Valeant (VRX) and Bill Ackman delivered another 2.8% consent vote to Allergan, bringing its total vote to call a special meeting to 33.8%, CNBC's David Faber reports, citing sources. A special meeting has been set for December 18, Faber added.
07:34 EDTFIVEFive Below September volatility elevated into Q2 and outlook
Five Below September call option implied volatility is at 61, October is at 47, February is at 39; compared to its 26-week average of 44 according to Track Data, suggesting large near term price movement into the expected release of Q2 on September 10.
September 3, 2014
10:00 EDTCYSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:47 EDTCYSCYS Investments downgraded to Hold from Buy at Maxim
Maxim downgraded CYS Investments to Hold saying the company's interest rate sensitivity disclosures indicate it has the highest risk to book value among mortgage REITs.
07:30 EDTCYSCYS Investments downgraded at Maxim
Subscribe for More Information
07:10 EDTCYSCYS Investments downgraded to Hold from Buy at Maxim
Subscribe for More Information
September 2, 2014
09:07 EDTAGNAllergan filed answer in federal court reponding to Valeant, Pershing claims
Subscribe for More Information
08:05 EDTAGNAllergan says Ozurdex apporved in EU for treatment of diabetic macular edema
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use